BIOTRONIK Excellence for Life

BIOTRONIK will participate at the Heart Rhythm Society (HRS) congress taking place in Chicago, Illinois. Join us for interactive sessions, lectures, hands-on experiences and networking with the BIOTRONIK professionals.

BIOTRONIK’s DX Technology has reached a remarkable milestone – 100,000 DX devices implanted worldwide.¹⁴ Backed by a rich history of clinical studies since 2009, that led to extensive evidence, this accomplishment underscores our unwavering dedication to innovation and patient care.

Available as a unique, single-lead ICD system equipped with a floating atrial dipole, DX ICDs:

• offer reliable, timely information about atrial arrhythmias and detect AF early.^{2, 3, 4, 5, 6}
• help clinicians monitor AF burden over time.³

In combination with BIOTRONIK Home Monitoring^® and optionally the BIOTRONIK Patient App, this AF management solution offers a comprehensive assessment of ICD patients and enables earlier, well-informed decision-making.³

We are pleased to invite you to our live webinar where renowned clinical experts will delve into the cutting-edge rate-responsive algorithm, Closed Loop Stimulation (CLS). This advanced technology is instrumental in effectively managing Vasovagal Syncopes and for preventing atrial arrhythmias in patients with Sinus Node Dysfunction.

For the first time, BIOTRONIK has earned a spot on the Forbes 2025 list of Best Employers for New Grads in the medical equipment and services industry.

At BIOTRONIK we are dedication to fostering a workplace where recent graduates can feel empowered to thrive, grow, and make a meaningful impact from day one.

BIOTRONIK, Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation have launched a first-of-its-kind research and innovation partnership to accelerate digital and translational cardiology. 

The collaboration combines clinical expertise, AI, connected health technologies, and cardiac device innovation to bring new digital solutions from research into patient care. Initial projects will focus on AI-driven tools, advanced simulation environments, and the next generation of cardiovascular specialists. 

BIOTRONIK Neuro’s Prospera spinal cord stimulation (SCS) system treats patients suffering from chronic pain, helping them embrace life again. The system uniquely features:

• RESONANCE™, the first and only multiphase stimulation paradigm
• Embrace One, a truly first-of-its-kind ecosystem that provides automatic, objective, remote daily monitoring

_{Prospera SCS System is approved in the US only and is not available outside of the US.}

_{Note: Embrace One is a support platform intended to help manage a patient’s experience with spinal cord stimulation. It is not intended to be used for medical diagnosis or medical treatment.}

Conduction System Pacing has kept the goal of 'physiologic pacing' at the forefront of cardiac rhythm in recent years. But what about physiologic heart rate?

We invite you to come learn from Drs. Matthew Evans, Jonathan Hsu, and David Hayes as they explore how BIOTRONIK's proprietary algorithm (CLS) gives heart rate control back to the patient's autonomic nervous system. 

What You'll Learn:

• How CLS puts the patient back in control of rate
• Recent clinical evidence showing CLS' role in reducing subclinical AF, improving quality of life and restoring chronotropic competence.
• A special focus on CLS impact on Heart Failure patients